Follow
Harsimar Kaur
Harsimar Kaur
Johns Hopkins University School of Medicine
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Clinical features and therapeutic outcomes in men with advanced prostate cancer and DNA mismatch repair gene mutations
ES Antonarakis, F Shaukat, PI Velho, H Kaur, E Shenderov, DM Pardoll, ...
European urology 75 (3), 378-382, 2019
1712019
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
K Uhteg, J Jarrett, M Richards, C Howard, E Morehead, M Geahr, L Gluck, ...
Journal of Clinical Virology 127, 104384, 2020
1242020
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
HB Kaur, LB Guedes, J Lu, L Maldonado, L Reitz, JR Barber, ...
Modern Pathology 31 (10), 1539-1552, 2018
842018
Homologous recombination deficiency (HRD) score in germline BRCA2-versus ATM-altered prostate cancer
TL Lotan, HB Kaur, DC Salles, S Murali, EM Schaeffer, JS Lanchbury, ...
Modern Pathology 34 (6), 1185-1193, 2021
692021
Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
S Wilkinson, H Ye, F Karzai, SA Harmon, NT Terrigino, DJ VanderWeele, ...
European Urology, 2021
512021
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer
HB Kaur, J Lu, LB Guedes, L Maldonado, L Reitz, JR Barber, ...
Human pathology 87, 95-102, 2019
402019
Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance
H Kaur, I Samarska, J Lu, F Faisal, BL Maughan, S Murali, K Asrani, ...
The Prostate 80 (12), 1012-1023, 2020
302020
mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation
K Asrani, A Sood, A Torres, D Georgess, P Phatak, H Kaur, A Dubin, ...
The Journal of clinical investigation 127 (11), 4001-4017, 2017
302017
Genomic and clinicopathologic characterization of ATM-deficient prostate cancer
H Kaur, DC Salles, S Murali, JL Hicks, M Nguyen, CC Pritchard, ...
Clinical Cancer Research 26 (18), 4869-4881, 2020
262020
mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation
K Asrani, S Murali, B Lam, CH Na, P Phatak, A Sood, H Kaur, Z Khan, ...
The Journal of clinical investigation 129 (12), 5584-5599, 2019
242019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy
P Isaacsson Velho, D Lim, H Wang, JC Park, HB Kaur, F Almutairi, ...
JCO precision oncology 3, 1-13, 2019
242019
CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer
FA Faisal, S Murali, H Kaur, T Vidotto, LB Guedes, DC Salles, V Kothari, ...
Clinical Cancer Research 26 (11), 2595-2602, 2020
202020
DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant‐cell features
TL Lotan, HB Kaur, AM Alharbi, CC Pritchard, JI Epstein
Histopathology 74 (6), 836-843, 2019
192019
SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy
FA Faisal, HB Kaur, JJ Tosoian, SA Tomlins, EM Schaeffer, TL Lotan
Prostate cancer and prostatic diseases 22 (4), 552-559, 2019
172019
Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer
AA Mendes, J Lu, HB Kaur, SL Zheng, J Xu, J Hicks, AB Weiner, ...
Cancer, 2022
152022
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer
HB Kaur, T Vidotto, AA Mendes, DC Salles, WB Isaacs, ES Antonarakis, ...
Cancer Immunology, Immunotherapy, 1-9, 2021
132021
PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations
HB Kaur, DC Salles, A Paulk, JI Epstein, JR Eshleman, TL Lotan
Histopathology 78 (2), 327-333, 2021
132021
Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas?
A Nambirajan, H Kaur, K Jangra, K Kaur, K Madan, SR Mathur, VK Iyer, ...
Cytopathology 29 (2), 163-171, 2018
92018
ATM loss in primary prostate cancer: Analysis of> 1000 cases using a validated clinical-grade immunohistochemistry (IHC) assay.
ES Antonarakis, HB Kaur, J Hicks, CC Pritchard, AM De Marzo, WB Isaacs, ...
Journal of Clinical Oncology 37 (15_suppl), 5069-5069, 2019
32019
Primary ureteral lymphoma presenting as bilateral obstructive uropathy
C Friedes, B Dietrick, H Kaur, AR Meyer, JS Winoker
Urology Case Reports 33, 101296, 2020
22020
The system can't perform the operation now. Try again later.
Articles 1–20